Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective Study Investigating Association of Expression of TK1 in Plasma-Derived Exosomes with Clinical Response to Palbociclib in Metastatic Breast Cancer Patients

Trial Profile

A Prospective Study Investigating Association of Expression of TK1 in Plasma-Derived Exosomes with Clinical Response to Palbociclib in Metastatic Breast Cancer Patients

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2018

At a glance

  • Drugs Palbociclib (Primary) ; Fulvestrant; Letrozole
  • Indications Advanced breast cancer
  • Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 15 Jun 2018 New trial record
    • 05 Jun 2018 Results (n=16) of the first clinical evaluation for mRNA levels and efficacy, presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top